Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1
Open Access
- 1 November 2017
- journal article
- Published by Elsevier BV in Acta Pharmaceutica Sinica. B
- Vol. 7 (6), 657-664
- https://doi.org/10.1016/j.apsb.2017.07.004
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81403002, 81473181, 81573501)
- First Affiliated Hospital of Zhengzhou University (201613)
- Innovative Entrepreneurship Program of High-level Talents in Dalian (2016RQ025)
This publication has 35 references indexed in Scilit:
- Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemiaBiochemical Pharmacology, 2017
- Efficacy and safety of icotinib in treating non-small cell lung cancer: a systematic evaluation and meta-analysis based on 15 studiesOncotarget, 2016
- Evaluation of Three Small Molecular Drugs for Targeted Therapy to Treat Nonsmall Cell Lung CancerChinese Medical Journal, 2016
- Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer TreatmentCurrent Cancer Drug Targets, 2016
- Relationship between icotinib hydrochloride exposure and clinical outcome in Chinese patients with advanced non–small cell lung cancerCancer, 2015
- Tyrosine kinase inhibitors (TKIs) in human and pet tumours with special reference to breast cancer: A comparative reviewCritical Reviews in Oncology/Hematology, 2013
- Impact of Ignoring Extraction Ratio When Predicting Drug-Drug Interactions, Fraction Metabolized, and Intestinal First-Pass ContributionDrug Metabolism and Disposition, 2010
- Comparison of the Drug-Drug Interactions Potential of Erlotinib and Gefitinib via Inhibition of UDP-GlucuronosyltransferasesDrug Metabolism and Disposition, 2009
- Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancerAnnals of Oncology, 2006
- HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECIDDrug Metabolism and Disposition, 2004